Corporate Profile

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel's largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

 

lnk Overview

Read More

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

lnk Stock Information

View All Stock Information

lnk Stock Information

View All Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

lnk Stock Information

View All Stock Information

News Releases

News and views about the Intercure.

16-Sep-22

Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders

HERZLIYA, Israel, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Intercure Ltd. (the “Company”) announces today the results of the Annual and Special General Meeting of shareholders of the Company, held on Thursday, September 15, 2022, in Bnei Brak, Israel (the “Meeting”).
15-Aug-22

InterCure Reports Record Breaking Second Quarter Financial Results

Record revenue of over $3 7 million i in the second quarter of 2022 Representing an annual run rate of $1 50 million Adjusted EBITDA ii for Q2 increased 90 % YoY to $ 9 million Net income of $6 million for the Q2 of 2022 compared to $2 million in Q2 of 2021 Tenth consecutive quarter of profitable
11-Aug-22

InterCure to Release its Q2 2022 Results and Hold a Conference Call

Conference call scheduled for Tuesday, August 16, 2022, at 8:30am ET NEW YORK and TORONTO and HERZLIYA, Israel, Aug. 11, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial

lnk News

Events
Investor events will be posted soon.

lnk Events

View All Events
Featured Reports
Aug 16, 2022